The retinoid induced pancreatic cancer redifferentiation-apoptosis sequence and the mitochondria: a suggested obligatory sequence of events.

作者: Tarek H El-Metwally , Parvis M Pour , None

DOI:

关键词:

摘要: Retinoic acid induces redifferentiation and apoptosis in pancreatic adenocarcinoma cell lines. Redifferentiation includes early reversion into aerobic metabolism as reflected by an increase of mitochondrial activity mass with normal membrane potential terminal ductal differentiation. Cells such a state either attempt to correct their DNA abnormalities or commit suicide apoptosis. In some systems, cells, the stem cells show transdifferentiate functional endocrine type. However, since it is impossible highly corrupted genome, eventually succumb Mitochondrial changes appear be enforcing factor for this process. The Transformation - Normalizing-redifferentiation Apoptosis sequence has been shown several studies, utilizing various types, apoptotic inducers, biomarkers time frames. Although studies have concomitant redifferentiation, others reported without prior redifferentiation. appropriate frame markers earlier changes, one would detect scenario similar retinoid model. This situation can achieved delaying reducing inducer concentration systems. final physiological fate terminally differentiated Similarly, suggested that degree normalizing transformed might expected former seemed obligatory at least retinoidpancreatic

参考文章(54)
Boisteau O, Cordel S, Grégoire M, Meflah K, Barbieux I, Lieubeau B, Induction de l'apoptose, in vitro et in vivo, sur cellules tumorales coliques de rat après traitement par le butyrate de sodium Bulletin Du Cancer. ,vol. 83, pp. 197- 204 ,(1996)
Leonard H Augenlicht, Barbara G Heerdt, Mitochondria: integrators in tumorigenesis? Nature Genetics. ,vol. 28, pp. 104- 105 ,(2001) , 10.1038/88800
Garry I. Abelev, Natalia L. Lazarevich, Control of differentiation in progression of epithelial tumors. Advances in Cancer Research. ,vol. 95, pp. 61- 113 ,(2006) , 10.1016/S0065-230X(06)95003-9
José M. Cuezva, Luciana K. Ostronoff, Javier Ricart, Miguel López de Heredia, Carlo M. Di Liegro, José M. Izquierdo, Mitochondrial biogenesis in the liver during development and oncogenesis. Journal of Bioenergetics and Biomembranes. ,vol. 29, pp. 365- 377 ,(1997) , 10.1023/A:1022450831360
J. Usukura, T. Wakabayashi, M. Teranishi, Y. Nishizawa, M. Wozniak, M. Karbowski, J.H. Spodnik, Opposite effects of microtubule-stabilizing and microtubule-destabilizing drugs on biogenesis of mitochondria in mammalian cells Journal of Cell Science. ,vol. 114, pp. 281- 291 ,(2001) , 10.11501/3181144
Chung-Liang Chien, Tung-Wei Chen, Yi-Shan Lin, Kuo-Shyan Lu, The Apoptotic Process of Human Bladder Carcinoma T24 Cells Induced by Retinoid Journal of Biomedical Science. ,vol. 11, pp. 631- 640 ,(2004) , 10.1007/BF02256129
Tarek H El-Metwally, Thomas E Adrian, None, Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model. Biochemical and Biophysical Research Communications. ,vol. 257, pp. 596- 603 ,(1999) , 10.1006/BBRC.1999.0502
H ALHALLAQ, J RIVER, M ZAMORA, H OIKAWA, G KARCZMAR, Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. International Journal of Radiation Oncology Biology Physics. ,vol. 41, pp. 151- 159 ,(1998) , 10.1016/S0360-3016(98)00038-8
Ting-Dong Zhang, Guo-Qiang Chen, Zhu-Gang Wang, Zhen-Yi Wang, Sai-Juan Chen, Zhu Chen, Arsenic trioxide, a therapeutic agent for APL. Oncogene. ,vol. 20, pp. 7146- 7153 ,(2001) , 10.1038/SJ.ONC.1204762